Case File
efta-efta01761910DOJ Data Set 10CorrespondenceEFTA Document EFTA01761910
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01761910
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Sent:
Tuesday, April 23, 2013 4:02 PM
To:
Epstein Jeffrey
Subject:
Fwd: Andrew Feldstein
Begin forwarded message:
From: Rosa da Silva =It;
Subject: Andrew Feldstein
Date: April 23, 2013 =1:58:28 AM EDT
To:
</=iv>
Dear Mr. Barak, Unfortunately, =ue to conflicting schedules, Andrew Feldstein is unable to meet this =eek. We
apologize for any inconvenience.
Many =hanks,
Rosa da Silva
(Asst to J.E. Staley)
Rosa da Silva
BlueMountain =apital Management, LLC
280 Park Avenue, =th Floor =ast
New York, NY =0017
This e-mail is intended only for the person =r entity to which it is addressed and may contain confidential and/or
=rivileged material. Any review, retransmission, dissemination or other =se of, or taking of any action in reliance upon,
the information in =his e-mail by persons or entities other than the intended recipient is =rohibited and may be
unlawful. If you received this in error, please =ontact the sender and delete the material from any =omputer.
This communication is for informational purposes only. =t is not intended as and does not constitute an offer or
solicitation =or the purchase or sale of any financial instrument or as an official =onfirmation of any transaction. All
market prices, data and other =nformation are not warranted as to completeness or accuracy and are =ubject to change
without notice. Any expected returns are provided for =llustrative purposes only and are not intended to serve as, and
must =ot be relied upon by any prospective investor as, a guaranty, an =ssurance, a prediction of a definitive statement
of fact or a =robability. Investment in funds managed by BlueMountain carries certain =isks, including the risk of loss of
principal. Unless indicated =therwise, performance results are presented net of fees and expenses. =ertain market and
economic events having an impact on performance may =ot repeat themselves. Any comments or statements made
EFTA_R1_00066982
EFTA01761910
herein do not =ecessarily reflect those of BlueMountain Capital Management, LLC or its =ffiliates. PAST PERFORMANCE
IS NOT NECESSARILY INDICATIVE OF FUTURE =ESULTS AND NO REPRESENTATION IS MADE THAT RESULTS SIMILAR TO
THOSE =HOWN CAN BE =CHIEVED.
=
2
EFTA_R1_00066983
EFTA01761911
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.